PMID: 
Reviews - 2xs6 mentioned but not cited (1)
- Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets. Ito Y, Hart JR, Vogt PK. Expert Opin Ther Targets 22 869-877 (2018)
Articles - 2xs6 mentioned but not cited (8)
- Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium. Cheung LW, Walkiewicz KW, Besong TM, Guo H, Hawke DH, Arold ST, Mills GB. Elife 4 e06866 (2015)
- A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes. Du Z, Uversky VN. Int J Mol Sci 18 E2010 (2017)
- Highly precise protein-protein interaction prediction based on consensus between template-based and de novo docking methods. Ohue M, Matsuzaki Y, Shimoda T, Ishida T, Akiyama Y. BMC Proc 7 S6 (2013)
- On the intrinsic disorder status of the major players in programmed cell death pathways. Uversky AV, Xue B, Peng Z, Kurgan L, Uversky VN. F1000Res 2 190 (2013)
- Significant reduction in errors associated with nonbonded contacts in protein crystal structures: automated all-atom refinement with PrimeX. Bell JA, Ho KL, Farid R. Acta Crystallogr D Biol Crystallogr 68 935-952 (2012)
- Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing. Yang X, Huang WT, Wu HY, He RQ, Ma J, Liu AG, Chen G. Oncol Rep 41 2241-2253 (2019)
- The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
- Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019. Li J, Guo S, Tan Y, Zhang J, Wu Z, Stalin A, Zhang F, Huang Z, Wu C, Liu X, Huang J, Wu J. Medicine (Baltimore) 102 e34866 (2023)
Articles citing this publication (7)
- Crystal structure of mammalian acid sphingomyelinase. Gorelik A, Illes K, Heinz LX, Superti-Furga G, Nagar B. Nat Commun 7 12196 (2016)
- Structure of Human Acid Sphingomyelinase Reveals the Role of the Saposin Domain in Activating Substrate Hydrolysis. Xiong ZJ, Huang J, Poda G, Pomès R, Privé GG. J Mol Biol 428 3026-3042 (2016)
- Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease. Zhou YF, Metcalf MC, Garman SC, Edmunds T, Qiu H, Wei RR. Nat Commun 7 13082 (2016)
- Crystal Structure of the Acid Sphingomyelinase-like Phosphodiesterase SMPDL3B Provides Insights into Determinants of Substrate Specificity. Gorelik A, Heinz LX, Illes K, Superti-Furga G, Nagar B. J Biol Chem 291 24054-24064 (2016)
- Characterization of Sphingomyelin Phosphodiesterase Expression in Bumblebee (Bombus lantschouensis). Han L, Ding G, Liu Y, Huang J, Wu J. J Insect Sci 18 (2018)
- Ligand-dependent and -independent regulation of human hepatic sphingomyelin phosphodiesterase acid-like 3A expression by pregnane X receptor and crosstalk with liver X receptor. Jeske J, Bitter A, Thasler WE, Weiss TS, Schwab M, Burk O. Biochem Pharmacol 136 122-135 (2017)
- Functionally comparable but evolutionarily distinct nucleotide-targeting effectors help identify conserved paradigms across diverse immune systems. Nicastro GG, Burroughs AM, Iyer LM, Aravind L. Nucleic Acids Res 51 11479-11503 (2023)